BORGHI, MARIA ORIETTA
BORGHI, MARIA ORIETTA
Dipartimento di Scienze Cliniche e di Comunità
Fibroblasts and Endothelial Cells in Three-Dimensional Models: A New Tool for Addressing the Pathogenesis of Systemic Sclerosis as a Prototype of Fibrotic Vasculopathies
2024 C. Bodio, A. Milesi, P.A. Lonati, C.B. Chighizola, A. Mauro, L.G. Pradotto, P.L. Meroni, M.O. Borghi, E. Raschi
Identification of two autoantigens recognised by circulating autoantibodies as potential biomarkers for diagnosing giant cell arteritis
2024 E. Pesce, M. Bombaci, S. Croci, M. Bonacini, C. Marvisi, C. Ricordi, S. Monti, F. Muratore, S. Abrignani, R. Caporali, M.O. Borghi, C. Salvarani, P.M. Villiger, R. Grifantini, P.L. Meroni
Exploring the multifaceted antitumor activity of axitinib in lung carcinoids
2024 M. Oldani, M.C. Cantone, G. Gaudenzi, S. Carra, A. Dicitore, D. Saronni, M.O. Borghi, A. Lombardi, M. Caraglia, L. Persani, G. Vitale
Nailfold Videocapillaroscopic Alterations as Markers of Microangiopathy in COVID-19 Patients
2023 R. Gualtierotti, S.E. Fox, F. Da Silva Lameira, A. Giachi, L.V.C. Valenti, M.O. Borghi, P. Luigi Meroni, M. Cugno, F. Payvandi
Antitumor Activity of Axitinib in Lung Carcinoids: A Preclinical Study
2023 A. Dicitore, G. Gaudenzi, S. Carra, M.C. Cantone, M. Oldani, D. Saronni, M.O. Borghi, J. Grotteschi, L. Persani, G. Vitale
Complement activation predicts negative outcomes in COVID-19: The experience from Northen Italian patients
2023 P.L. Meroni, S. Croci, P.A. Lonati, F. Pregnolato, L. Spaggiari, G. Besutti, M. Bonacini, I. Ferrigno, A. Rossi, G. Hetland, I. Hollan, M. Cugno, F. Tedesco, M.O. Borghi, C. Salvarani
Preclinical Evaluation of Novel Tyrosine-Kinase Inhibitors in Medullary Thyroid Cancer
2022 D. Saronni, G. Gaudenzi, A. Dicitore, S. Carra, M.C. Cantone, M.O. Borghi, A. Barbieri, L. Mignani, L.J. Hofland, L. Persani, G. Vitale
Role of epigenetic therapy in the modulation of tumor growth and migration in human castration-resistant prostate cancer cells with neuroendocrine differentiation
2022 A. Dicitore, M.G. Bacalini, D. Saronni, G. Gaudenzi, M.C. Cantone, G. Gelmini, E.S. Grassi, D. Gentilini, M.O. Borghi, A.M. Di Blasio, L. Persani, P. Garagnani, C. Franceschi, G. Vitale
Production of anti-{PF}4 antibodies in antiphospholipid antibody-positive patients is not affected by {COVID}-19 vaccination
2022 P.A. Lonati, C. Bodio, M. Scavone, G. Martini, E. Pesce, A. Bandera, A. Lombardi, M. Gerosa, F. Franceschini, A. Tincani, G. Podda, S. Abrignani, R. Grifantini, M.N. Cattaneo, M.O. Borghi, P. Luigi Meroni
Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers
2022 M.O. Borghi, M. Bombaci, C. Bodio, P.A. Lonati, A. Gobbini, M. Lorenzo, E. Torresani, A. Dubini, I. Bulgarelli, F. Solari, F. Pregnolato, A. Bandera, A. Gori, G. Parati, S. Abrignani, R. Grifantini, P.L. Meroni
Decompensation in Direct-Acting Antiviral Cured Hepatitis C Virus Compensated Patients With Clinically Significant Portal Hypertension: Too Rare to Warrant Universal Β-Blocker Therapy
2021 G. Tosetti, E. Degasperi, E. Farina, R. D'Ambrosio, R. Soffredini, M. Borghi, V. La Mura, M. Primignani, P. Lampertico
Efficacy of a novel second-generation somatostatin-dopamine chimera (TBR-065) in human medullary thyroid cancer: a preclinical study
2021 A. Dicitore, M.C. Cantone, G. Gaudenzi, D. Saronni, S. Carra, M.O. Borghi, M. Albertelli, D. Ferone, L.J. Hofland, L. Persani, G. Vitale
EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies
2021 F. Pregnolato, M. Gerosa, M.G. Raimondo, C. Comerio, F. Bartoli, P.A. Lonati, M.O. Borghi, B. Acaia, M.W. Ossola, E. Ferrazzi, L. Trespidi, P.L. Meroni, C.B. Chighizola
Complement activation and endothelial perturbation parallel COVID-19 severity and activity
2021 M. Cugno, P.L. Meroni, R. Gualtierotti, S. Griffini, E. Grovetti, A. Torri, P. Lonati, C. Grossi, M.O. Borghi, C. Novembrino, M. Boscolo, S.C. Uceda Renteria, L. Valenti, G. Lamorte, M. Manunta, D. Prati, A. Pesenti, F. Blasi, G. Costantino, A. Gori, A. Bandera, F. Tedesco, F. Peyvandi
Vandetanib versus cabozantinib in medullary thyroid carcinoma: A focus on anti‐angiogenic effects in zebrafish model
2021 S. Carra, G. Gaudenzi, A. Dicitore, D. Saronni, M.C. Cantone, A. Plebani, A. Ghilardi, M.O. Borghi, L.J. Hofland, L. Persani, G. Vitale
Histone deacetylase inhibitors ameliorate morphological defects and hypoexcitability of iPSC-neurons from Rubinstein-Taybi patients
2021 V. Alari, P. Scalmani, P.F. Ajmone, S. Perego, S. Avignone, I. Catusi, P.A. Lonati, M.O. Borghi, P. Finelli, B. Terragni, M. Mantegazza, S. Russo, L. Larizza
Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases
2021 G. Barturen, S. Babaei, F. Català-Moll, M. Martínez-Bueno, Z. Makowska, J. Martorell-Marugán, P. Carmona-Sáez, D. Toro-Domínguez, E. Carnero-Montoro, M. Teruel, M. Kerick, M. Acosta-Herrera, L. Le Lann, C. Jamin, J. Rodríguez-Ubreva, A. García-Gómez, J. Kageyama, A. Buttgereit, S. Hayat, J. Mueller, R. Lesche, M. Hernandez-Fuentes, M. Juarez, T. Rowley, I. White, C. Marañón, T. Gomes Anjos, N. Varela, R. Aguilar-Quesada, F.J. Garrancho, A. López-Berrio, M. Rodriguez Maresca, H. Navarro-Linares, I. Almeida, N. Azevedo, M. Brandão, A. Campar, R. Faria, F. Farinha, A. Marinho, E. Neves, A. Tavares, C. Vasconcelos, E. Trombetta, G. Montanelli, B. Vigone, D. Alvarez-Errico, T. Li, R. Blanco Alonso, A. Corrales Martínez, F. Genre, R. López Mejías, M.A. Gonzalez-Gay, S. Remuzgo, B. Ubilla Garcia, R. Cervera, G. Espinosa, I. Rodríguez-Pintó, E. De Langhe, J. Cremer, R. Lories, D. Belz, N. Hunzelmann, N. Baerlecken, K. Kniesch, T. Witte, M. Lehner, G. Stummvoll, M. Zauner, M.A. Aguirre-Zamorano, N. Barbarroja, M.C. Castro-Villegas, E. Collantes-Estevez, E. de Ramon, I. Díaz Quintero, A. Escudero-Contreras, M.C. Fernández Roldán, Y. Jiménez Gómez, I. Jiménez Moleón, R. Lopez-Pedrera, R. Ortega-Castro, N. Ortego, E. Raya, C. Artusi, M. Gerosa, P. Luigi Meroni, T. Schioppo, A. De Groof, J. Ducreux, B. Lauwerys, A. Maudoux, D. Cornec, V. Devauchelle-Pensec, S. Jousse-Joulin, P. Jouve, B. Rouvière, A. Saraux, Q. Simon, M. Alvarez, C. Chizzolini, A. Dufour, D. Wynar, A. Balog, M. Bocskai, M. Deák, S. Dulic, G. Kádár, L. Kovács, Q. Cheng, V. Gerl, F. Hiepe, L. Khodadadi, S. Thiel, E. de Rinaldis, S. Rao, R.J. Benschop, C. Chamberlain, E.R. Dow, Y. Ioannou, L. Laigle, J. Marovac, J. Wojcik, Y. Renaudineau, M.O. Borghi, J. Frostegård, J. Martín, L. Beretta, E. Ballestar, F. Mcdonald, J. Pers, M.E. Alarcón-Riquelme
Effetti a lungo termine degli analoghi della somatostatina in linee cellulari di tumori ipofisari GH-secernenti.
2020 D. Saronni, A. Dicitore, G. Gaudenzi, S. Carra, M.C. Cantone, M.O. Borghi, L. Persani, G. Vitale
Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors
2020 C. Bodio, C. Grossi, F. Pregnolato, E.G. Favalli, M. Biggioggero, A. Marchesoni, A. Murgo, M. Filippini, P. Migliorini, R. Caporali, R. Pellerito, F. Ciccia, P. Sarzi-Puttini, F. Perosa, G. Paolazzi, I. Hollan, K. Bendtzen, P.L. Meroni, M.O. Borghi
Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis
2020 E. Raschi, D. Privitera, C. Bodio, P.A. Lonati, M.O. Borghi, F. Ingegnoli, P.L. Meroni, C.B. Chighizola